Viracta Therapeutics, Inc. presented updated results today at the 2019 ASCO Annual Meeting from the Ph1b portion of the ongoing Phase 1b/2 clinical trial of nanatinostat in combination with the...

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces that a post-hoc analysis of the MAVORIC trial (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) is being presented today at the 2019...

The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing key stakeholders in the specialty pharmacy industry, has named Andy Slavitt, former Center for Medicare...

Honeywell (NYSE: HON) has unveiled a new compact "fly-by-wire" system that is approximately the size of a paperback book. The computer packs the "brains" of an airliner's flight controls into one...

-- 80% overall response rate in patients with relapsed or refractory follicular lymphoma -- -- Intermittent dosing schedule demonstrates comparable overall response rates with lower rate of...